TrianglePUBLICATIONS · 3493432
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 1987 Apr 9
- First author
- Rosenberg SA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rosenberg SA
- type
- Author
- name
- Lotze MT
- type
- Author
- name
- Muul LM
- type
- Author
- name
- Chang AE
- type
- Author
- name
- Avis FP
- type
- Author
- name
- Leitman S
- type
- Author
- name
- Linehan WM
- type
- Author
- name
- Robertson CN
- type
- Author
- name
- Lee RE
- type
- Author
- name
- Rubin JT
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rosenberg SA
- type
- Author
- name
- Lotze MT
- type
- Author
- name
- Muul LM
- type
- Author
- name
- Chang AE
- type
- Author
- name
- Avis FP
- type
- Author
- name
- Leitman S
- type
- Author
- name
- Linehan WM
- type
- Author
- name
- Robertson CN
- type
- Author
- name
- Lee RE
- type
- Author
- name
- Rubin JT
- type
- Author
- bibliography ids
- nci-bib-09f9bc514935267ea9ff1847
- book metadata
- content sha256
- c7f8bccea2c1cb1ca9c20ac4153f501e256b1f8d9fab049c180bbd04892303ff
- document type
- citation
- dois
- 10.1056/NEJM198704093161501
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3493432
- immutable id
- pubmed:3493432@c7f8bccea2c1cb1ca9c20ac4153f501e256b1f8d9fab049c180bbd04892303ff
- journal
- abbreviation
- N Engl J Med
- issn electronic
- Source null
- issn print
- 0028-4793
- issue
- 15
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 889-97
- volume
- 316
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3493432
- provenance
- batch id
- a2059861e4099d0f54b4
- provider
- NCBI PubMed ESummary
- record sha256
- efb8e797354bf66099385b12485c8a406d674a8dd77486ea7da7f31e7b962029
- response sha256
- d338ccf62b1e9c7837730008fcd5c2d96e2453a423d7e449285b89d28e5a3bc3
- retrieved at
- 2026-09-09T23:45:12.786635+00:00
- publication date
- display
- 1987 Apr 9
- precision
- day
- year
- 1987
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3493432/
- title
- A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.
Preserved source evidence · Not medical advice